Orekhov AN - Search Results

1

NLPR3 Inflammasomes and Their Significance for Atherosclerosis.

Poznyak AV, Melnichenko AA, Wetzker R, Gerasimova EV, Orekhov AN. Poznyak AV, et al. Among authors: orekhov an. Biomedicines. 2020 Jul 10;8(7):205. doi: 10.3390/biomedicines8070205. Biomedicines. 2020. PMID: 32664349 Free PMC article. Review.

2

Antigenic differences between apo-B in native and circulating modified low-density lipoproteins.

Suprun IV, Mel'nichenko AA, Yanushevskaya EV, Vlasik TN, Sobenin IA, Panasenko OM, Orekhov AN. Suprun IV, et al. Among authors: orekhov an. Bull Exp Biol Med. 2004 Jul;138(1):42-4. doi: 10.1023/b:bebm.0000046934.76907.9d. Bull Exp Biol Med. 2004. PMID: 15514719

3

Low ionic strength promotes association of circulating modified LDL in human blood.

Panasenko OM, Suprun IV, Mel'nichenko AA, Sobenin IA, Orekhov AN. Panasenko OM, et al. Among authors: orekhov an. Bull Exp Biol Med. 2004 Sep;138(3):248-50. doi: 10.1007/s10517-005-0012-0. Bull Exp Biol Med. 2004. PMID: 15665915

4

Desialylation decreases the resistance of apo B-containing lipoproteins to aggregation and increases their atherogenic potential.

Mel'nichenko AA, Tertov VV, Ivanova OA, Aksenov DV, Sobenin IA, Popov EV, Kaplun VV, Suprun IV, Panasenko OM, Orekhov AN. Mel'nichenko AA, et al. Among authors: orekhov an. Bull Exp Biol Med. 2005 Jul;140(1):51-4. doi: 10.1007/s10517-005-0409-9. Bull Exp Biol Med. 2005. PMID: 16254619

5

Phospholipid hydrolysis with phospholipases A2 and C impairs apolipoprotein B-100 conformation on the surface of low density lipoproteins by reducing their association resistance.

Aksenov DV, Mel'nichenko AA, Suprun IV, Yanushevskaya EV, Vlasik TN, Sobenin IA, Panasenko OM, Orekhov AN. Aksenov DV, et al. Among authors: orekhov an. Bull Exp Biol Med. 2005 Oct;140(4):419-22. doi: 10.1007/s10517-005-0508-7. Bull Exp Biol Med. 2005. PMID: 16671570

6

Proteolysis of apoprotein B-100 impairs its topography on LDL surface and reduces LDL association resistance.

Panasenko OM, Aksenov DV, Mel'nichenko AA, Suprun IV, Yanushevskaya EV, Vlasik TN, Sobenin IA, Orekhov AN. Panasenko OM, et al. Among authors: orekhov an. Bull Exp Biol Med. 2005 Nov;140(5):521-5. doi: 10.1007/s10517-006-0013-7. Bull Exp Biol Med. 2005. PMID: 16758614

7

Antiatherogenic effect of grape flavonoids in an ex vivo model.

Nikitina NA, Sobenin IA, Myasoedova VA, Korennaya VV, Mel'nichenko AA, Khalilov EM, Orekhov AN. Nikitina NA, et al. Among authors: orekhov an. Bull Exp Biol Med. 2006 Jun;141(6):712-5. doi: 10.1007/s10517-006-0260-7. Bull Exp Biol Med. 2006. PMID: 17364057 English, Russian.

8

The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.

Sobenin IA, Suprun IV, Karagodin VP, Feoktistov AS, Melnichenko AA, Orekhov AN. Sobenin IA, et al. Among authors: orekhov an. J Lipids. 2011;2011:254267. doi: 10.1155/2011/254267. Epub 2011 Nov 17. J Lipids. 2011. PMID: 22175031 Free PMC article.

9

Pluronic block copolymers inhibit low density lipoprotein self-association.

Melnichenko AA, Aksenov DV, Myasoedova VA, Panasenko OM, Yaroslavov AA, Sobenin IA, Bobryshev YV, Orekhov AN. Melnichenko AA, et al. Among authors: orekhov an. Lipids. 2012 Oct;47(10):995-1000. doi: 10.1007/s11745-012-3699-5. Epub 2012 Jul 14. Lipids. 2012. PMID: 22797973

10

[Cholesterol of circulating immune complexes as biomarker of atherosclerosis].

Sobenin IA, Karagodin VP, Mel'nichenko AA, Orekhov AN. Sobenin IA, et al. Among authors: orekhov an. Patol Fiziol Eksp Ter. 2012 Jul-Sep;(3):99-103. Patol Fiziol Eksp Ter. 2012. PMID: 23072120 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

643 results

Search Page